Cervical Adenocarcinoma (DBCOND0029359)

Identifiers

Synonyms
Adenocarcinoma of the Cervix / Cervical adenocarcinoma / Carcinoma cervix uteri: [adenocarcinoma] or [invasive] / Adenocarcinoma of cervix (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00217633
Pelvic Exenteration in Treating Patients With Recurrent Cervical CancerNo drug interventionstreatment2completed
NCT01048853
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01267253
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT00559377
FDG and FMISO PET Hypoxia Evaluation in Cervical CancerNo drug interventionsdiagnostic2completed
NCT01693783
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancertreatment2completed
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV TestNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03738228
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancertreatment1active_not_recruiting
NCT02257528
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancertreatment2active_not_recruiting
NCT02880007
Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancertreatment2completed
NCT01281852
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancertreatment1completed
NCT00309959
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT00068549
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancertreatment1completed
NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumorstreatment2active_not_recruiting
NCT00924066
Ixabepilone to Treat Cervical Cancertreatment2terminated
NCT01266460
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT01649089
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01026792
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgerytreatment2completed
NCT00017004
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemiasupportive_care3completed
NCT00416455
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerNo drug interventionsdiagnostic1 / 2completed
NCT01414608
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancertreatment3completed
NCT00262821
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancertreatment3terminated
NCT02140021
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and CancerNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT01295502
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancertreatment1unknown_status
NCT01101451
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgerytreatment3unknown_status
NCT00064077
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervixtreatment3completed
NCT01266447
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT02164461
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancertreatment1completed
NCT01992861
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerNo drug interventionsNot AvailableNot Availableterminated
NCT02466971
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancerstreatment3active_not_recruiting
NCT03834571
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Womentreatment2withdrawn
NCT02020707
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancerstreatment1completed
NCT00460356
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesNo drug interventionsNot AvailableNot Availablecompleted
NCT01711515
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancertreatment1completed
NCT04622670
Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00039442
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT00897442
Collecting Tumor Samples From Patients With Gynecological TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00070317
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerdiagnosticNot Availableterminated
NCT00057863
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancertreatment2completed
NCT00369122
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancertreatment2completed
NCT05210348
Clinical Evaluation of Detection of High Risk HPV in UrineNo drug interventionsNot AvailableNot Availableunknown_status
NCT00389974
Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgerytreatment2completed
NCT06543576
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancertreatment1 / 2not_yet_recruiting
NCT00803062
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancertreatment3completed
NCT02562729
Complete Nerve-Sparing Radical Hysterectomy for Cervical CancerNo drug interventionstreatment2completed
NCT00054444
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancertreatment1completed
NCT02921269
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancertreatment2completed
NCT03742869
HPV Integration and Tumorigenesis of Uterine Cervical AdenocarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00104910
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancertreatment1completed
NCT01835171
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancertreatment2active_not_recruiting
NCT01639625
Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local ApplicationNot Available2completed
NCT02868892
A Study of Pemetrexed in Recurrent Cervical Adenocarcinomastreatment2terminated